Standard BioTools Price to Book Ratio 2010-2025 | LAB
Historical price to book ratio values for Standard BioTools (LAB) over the last 10 years. The current price to book ratio for Standard BioTools as of July 29, 2025 is 1.19.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Standard BioTools Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-29 | 1.39 | 1.16 | |
| 2025-03-31 | 1.08 | $1.20 | 0.90 |
| 2024-12-31 | 1.75 | $1.25 | 1.40 |
| 2024-09-30 | 1.93 | $1.31 | 1.47 |
| 2024-06-30 | 1.77 | $1.37 | 1.29 |
| 2024-03-31 | 2.71 | $1.52 | 1.79 |
| 2023-12-31 | 2.21 | $2.03 | 1.09 |
| 2023-09-30 | 2.90 | $2.26 | 1.28 |
| 2023-06-30 | 1.93 | $2.50 | 0.77 |
| 2023-03-31 | 1.95 | $2.72 | 0.72 |
| 2022-12-31 | 1.17 | $2.89 | 0.40 |
| 2022-09-30 | 1.10 | $3.14 | 0.35 |
| 2022-06-30 | 1.60 | $3.48 | 0.46 |
| 2022-03-31 | 3.59 | $0.29 | 12.53 |
| 2021-12-31 | 3.92 | $1.23 | 3.19 |
| 2021-09-30 | 6.59 | $1.30 | 5.07 |
| 2021-06-30 | 6.16 | $1.44 | 4.29 |
| 2021-03-31 | 4.52 | $1.64 | 2.76 |
| 2020-12-31 | 6.00 | $1.87 | 3.22 |
| 2020-09-30 | 7.43 | $2.05 | 3.62 |
| 2020-06-30 | 4.01 | $1.86 | 2.15 |
| 2020-03-31 | 2.54 | $2.00 | 1.27 |
| 2019-12-31 | 3.48 | $2.20 | 1.58 |
| 2019-09-30 | 4.63 | $2.34 | 1.98 |
| 2019-06-30 | 12.32 | $2.49 | 4.95 |
| 2019-03-31 | 13.29 | $2.64 | 5.03 |
| 2018-12-31 | 8.62 | $1.46 | 5.90 |
| 2018-09-30 | 7.49 | $0.57 | 13.14 |
| 2018-06-30 | 5.96 | $0.89 | 6.70 |
| 2018-03-31 | 5.84 | $1.25 | 4.68 |
| 2017-12-31 | 5.89 | $0.80 | 7.38 |
| 2017-09-30 | 5.04 | $1.01 | 4.98 |
| 2017-06-30 | 4.04 | $0.81 | 4.96 |
| 2017-03-31 | 5.69 | $1.31 | 4.33 |
| 2016-12-31 | 7.28 | $1.82 | 3.99 |
| 2016-09-30 | 8.01 | $2.33 | 3.43 |
| 2016-06-30 | 9.03 | $2.90 | 3.11 |
| 2016-03-31 | 8.07 | $3.43 | 2.36 |
| 2015-12-31 | 10.81 | $3.98 | 2.71 |
| 2015-09-30 | 8.11 | $4.31 | 1.88 |
| 2015-06-30 | 24.20 | $4.61 | 5.25 |
| 2015-03-31 | 42.10 | $4.96 | 8.49 |
| 2014-12-31 | 33.73 | $5.31 | 6.36 |
| 2014-09-30 | 24.50 | $5.47 | 4.48 |
| 2014-06-30 | 29.40 | $5.75 | 5.12 |
| 2014-03-31 | 44.07 | $5.98 | 7.37 |
| 2013-12-31 | 38.28 | $3.74 | 10.25 |
| 2013-09-30 | 21.94 | $3.79 | 5.79 |
| 2013-06-30 | 17.46 | $3.86 | 4.52 |
| 2013-03-31 | 18.51 | $3.94 | 4.70 |
| 2012-12-31 | 14.31 | $4.01 | 3.57 |
| 2012-09-30 | 17.00 | $4.11 | 4.14 |
| 2012-06-30 | 15.04 | $2.37 | 6.34 |
| 2012-03-31 | 15.73 | $2.53 | 6.21 |
| 2011-12-31 | 13.16 | $2.80 | 4.70 |
| 2011-09-30 | 13.93 | $2.92 | 4.76 |
| 2011-06-30 | 16.77 | $3.12 | 5.38 |
| 2011-03-31 | 14.31 | $3.50 | 4.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.539B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.813B | 60.83 |
| Hims & Hers Health (HIMS) | United States | $13.134B | 136.46 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| Tempus AI (TEM) | United States | $10.733B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.377B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.856B | 60.24 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.803B | 0.00 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Azenta (AZTA) | United States | $1.562B | 72.62 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Omnicell (OMCL) | United States | $1.358B | 23.97 |
| Evolent Health (EVH) | United States | $1.133B | 96.50 |
| Claritev (CTEV) | United States | $0.664B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.428B | 128.00 |
| TruBridge (TBRG) | United States | $0.347B | 771.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.244B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| CapsoVision (CV) | United States | $0.202B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.120B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |